SITE011-0239

SITE011 (ITA) › SITE011-0239

SITE011-0239

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE011 (ITA) · Dr. Jansen
consented 2026-06-15

enrolled

AEs

3

Serious

2

Dropout signal

–

Adverse events

3

Grade 3 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-03-09 (study day 81); relationship: not assessed; serious criteria: hospitalization

severe serious under_review

Grade 1 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2023-02-14 (study day 58); relationship: not assessed

mild assessed

Grade 4 Pneumonitis — outcome: RECOVERED/RESOLVED; onset 2023-01-31 (study day 44); relationship: not assessed; serious criteria: life-threatening

severe serious assessed

Data queries

0

No data queries. Open queries would appear here for this patient.